Research Papers and Book Chapters
Oct 2023
Explaining in-vitro to in-vivo efficacy correlations in oncology pre-clinical development via a semi-mechanistic mathematical model.
Seda Author(s) H.B. Mistry
Date: Oct 2023
Published: Journal of Pharmacokinetics and Pharmacodynamics
Oct 2023
Radius additivity score: a novel combination index for tumour growth inhibition in fixed-dose xenograft studies
Seda Author(s) N. Melillo, J. Dickinson, H. B. Mistry
Date: Oct 2023
Published: Frontiers in Oncology
Apr 2023
In depth characterization of physicochemical critical quality attributes of a clinical drug-dendrimer conjugate
Seda Author(s) C. Patterson
Date: Apr 2023
Published: International Journal of Pharmaceutics
Mar 2023
Precise and systematic end group chemistry modifications on PAMAM and poly(l-lysine) dendrimers to improve cytosolic delivery of mRNA
Seda Author(s) F. Joubert
Date: Mar 2023
Published: Journal of Controlled Release
Nov 2022
The Global Characterisation of a Drug-Dendrimer Conjugate – PEGylated poly-lysine Dendrimer
Seda Author(s) C. Patterson
Date: Nov 2022
Published: Journal of Pharmaceutical Sciences
September 2022
Determining bioequivalence possibilities of long acting injectables through population PK modelling
Seda Author(s) J. Dickinson, H. Dickinson, L. Ruston, H.B. Mistry, C. Patterson, P.A. Dickinson
Date: September 2022
Published: European Journal of Pharmaceutical Sciences
May 2022
Developing Clinically Relevant Dissolution Specifications (CRDSs) for Oral Drug Products: Virtual Webinar Series
Seda Author(s) P.A. Dickinson
Date: May 2022
Published: Pharmaceutics
Feb 2022
Developing Cannabinoid Science in the UK: Moving from the Security to the Health Domain
Seda Author(s) P.A. Dickinson
Date: Feb 2022
Published: Decalogue / The Centre for Medicinal Cannabis
Jan 2022
Biopharmaceutics: From Fundamentals to Industrial Practice
Seda Author(s) P.A. Dickinson, L. Ruston, S. Budhdeo, W. W. Lee, C. Patterson
Date: Jan 2022
Published: Wiley, Edited by Hannah Batchelor
Jan 2021
Exploring a model-based analysis of patient derived xenograft studies in oncology drug development
Seda Author(s) J. Dickinson, M. de Matas, P.A. Dickinson, H. Mistry
Date: Jan 2021
Published: PeerJ
Jan 2021
Design and optimisation of dendrimer-conjugated Bcl-2/xL inhibitor, AZD0466, with improved therapeutic index for cancer therapy
Seda Author(s) C. Patterson
Date: Jan 2021
Published: Communications Biology
Dec 2020
Predicting bioavailability of monoclonal antibodies after subcutaneous administration: Open innovation challenge
Seda Author(s) C. Patterson
Date: Dec 2020
Published: Advanced Drug Delivery Reviews